DE3851584T2 - Gegen Allergie wirkende Benzothiophene und neue und andere ausgewählte Benzothiophene, beide mit Wirkung zur Behandlung von akuten Atmungsangstanzeichen. - Google Patents

Gegen Allergie wirkende Benzothiophene und neue und andere ausgewählte Benzothiophene, beide mit Wirkung zur Behandlung von akuten Atmungsangstanzeichen.

Info

Publication number
DE3851584T2
DE3851584T2 DE3851584T DE3851584T DE3851584T2 DE 3851584 T2 DE3851584 T2 DE 3851584T2 DE 3851584 T DE3851584 T DE 3851584T DE 3851584 T DE3851584 T DE 3851584T DE 3851584 T2 DE3851584 T2 DE 3851584T2
Authority
DE
Germany
Prior art keywords
benzothiophenes
respiratory distress
allergic
effective
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3851584T
Other languages
English (en)
Other versions
DE3851584D1 (de
Inventor
David Thomas Connor
Roderick Joseph Sorenson
Michael David Mullican
David Orel Thueson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of DE3851584D1 publication Critical patent/DE3851584D1/de
Application granted granted Critical
Publication of DE3851584T2 publication Critical patent/DE3851584T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE3851584T 1987-07-14 1988-07-13 Gegen Allergie wirkende Benzothiophene und neue und andere ausgewählte Benzothiophene, beide mit Wirkung zur Behandlung von akuten Atmungsangstanzeichen. Expired - Fee Related DE3851584T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7355487A 1987-07-14 1987-07-14
US19169988A 1988-05-17 1988-05-17

Publications (2)

Publication Number Publication Date
DE3851584D1 DE3851584D1 (de) 1994-10-27
DE3851584T2 true DE3851584T2 (de) 1995-01-26

Family

ID=26754606

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3851584T Expired - Fee Related DE3851584T2 (de) 1987-07-14 1988-07-13 Gegen Allergie wirkende Benzothiophene und neue und andere ausgewählte Benzothiophene, beide mit Wirkung zur Behandlung von akuten Atmungsangstanzeichen.

Country Status (16)

Country Link
EP (1) EP0299457B1 (de)
JP (1) JP2672980B2 (de)
KR (1) KR970011580B1 (de)
CN (1) CN1031084A (de)
AT (1) ATE111908T1 (de)
AU (1) AU605070B2 (de)
CA (1) CA1330562C (de)
DE (1) DE3851584T2 (de)
DK (1) DK175933B1 (de)
ES (1) ES2063747T3 (de)
FI (1) FI91256C (de)
IE (1) IE64995B1 (de)
NO (1) NO170886C (de)
NZ (1) NZ225378A (de)
PH (1) PH25958A (de)
PT (1) PT87975B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689129B1 (fr) * 1992-03-27 1995-05-12 Atochem Elf Sa Nouveaux dérivés de l'acide 3-mercapto-2-thénoique et leurs procédés de préparation.
US5426191A (en) * 1993-12-03 1995-06-20 Warner-Lambert Company Process for the synthesis of 3-chlorobenzo[b]thiophene-2-carbonyl chlorides
FR2719474B1 (fr) 1994-05-05 1996-05-31 Oreal Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.
US6203803B1 (en) 1994-12-14 2001-03-20 Societe L'oreal S.A. Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained
FR2719476B1 (fr) * 1994-05-05 1997-05-23 Oreal Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.
FR2728166A1 (fr) 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
FR2728793A1 (fr) 1994-12-28 1996-07-05 Oreal Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
DE19620508A1 (de) * 1996-05-22 1997-11-27 Hoechst Ag Schwefelenthaltende heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung
US20040259926A1 (en) * 2003-06-05 2004-12-23 Bruendl Michelle M. 3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
BRPI0410940A (pt) * 2003-06-05 2006-08-29 Warner Lambert Co benzo[b]tiofenos substituìdos com cicloalquilsulfanila como agentes terapêuticos
EP1644360A1 (de) * 2003-06-05 2006-04-12 Warner-Lambert Company LLC 3-substituierte indole und ihre derivate als therapeutische mittel
CA2527573A1 (en) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents
WO2004108716A1 (en) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc 3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents
WO2005023800A1 (en) * 2003-09-04 2005-03-17 Warner-Lambert Company Llc Halo substituted benzo`b! thiophenes with pi3k inhibitory activity as therapeutic agents
FR2862645B1 (fr) * 2003-11-20 2007-06-22 Merck Sante Sas Composes antidiabetiques contenant des derives benzofuranes, benzothiophenes
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140785A (en) * 1978-05-08 1979-02-20 E. I. Du Pont De Nemours And Company N-(benzothienopyrazol)amide antirhinoviral agents
US4432986A (en) * 1979-06-18 1984-02-21 Riker Laboratories, Inc. Tetrazoles bonded to certain polycyclic aromatic systems and anti-allergic use thereof
EP0146243A1 (de) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Lipoxygenase-Inhibitoren
GB8401288D0 (en) * 1984-01-18 1984-02-22 Pfizer Ltd Therapeutic agents
GB8426474D0 (en) * 1984-10-19 1984-11-28 Ici America Inc Heterocyclic amides
ZA858748B (en) * 1984-12-10 1987-06-24 Warner Lambert Co Novel benzothiophenes and benzofurans having antiallergy activity
IE58555B1 (en) * 1984-12-10 1993-10-06 Warner Almbert Company Novel benzothiophenes and benzofurans having antiallergy activity
US4675332A (en) * 1984-12-10 1987-06-23 Warner-Lambert Company Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
US4748183A (en) * 1986-06-13 1988-05-31 Warner-Lambert Company N-1H-tetrazol-5-yl-2-thiophene carboxamides, N-1H-tetrazol-5-yl-2-pyrrole carboxamides, N-1H-tetrazol-5-yl-2-furan carboxamides, and anti-allergic and anti-inflammatory use thereof
EP0253650A3 (de) * 1986-07-18 1989-09-13 Eli Lilly And Company Benzothiophen-Derivate

Also Published As

Publication number Publication date
CA1330562C (en) 1994-07-05
EP0299457B1 (de) 1994-09-21
FI883300A (fi) 1989-01-15
PT87975B (pt) 1995-03-01
NO170886B (no) 1992-09-14
EP0299457A2 (de) 1989-01-18
FI91256C (fi) 1994-06-10
DK388488D0 (da) 1988-07-12
NO883100L (no) 1989-01-16
KR970011580B1 (ko) 1997-07-12
NO883100D0 (no) 1988-07-12
CN1031084A (zh) 1989-02-15
AU1857788A (en) 1989-01-19
NZ225378A (en) 1992-03-26
ES2063747T3 (es) 1995-01-16
FI883300A0 (fi) 1988-07-11
PH25958A (en) 1992-01-13
PT87975A (pt) 1989-06-30
DE3851584D1 (de) 1994-10-27
JPH01110682A (ja) 1989-04-27
FI91256B (fi) 1994-02-28
KR890002129A (ko) 1989-04-08
AU605070B2 (en) 1991-01-03
EP0299457A3 (en) 1989-07-19
IE881879L (en) 1989-01-14
NO170886C (no) 1992-12-23
DK175933B1 (da) 2005-07-18
JP2672980B2 (ja) 1997-11-05
IE64995B1 (en) 1995-09-20
DK388488A (da) 1989-01-15
ATE111908T1 (de) 1994-10-15

Similar Documents

Publication Publication Date Title
DE3851584D1 (de) Gegen Allergie wirkende Benzothiophene und neue und andere ausgewählte Benzothiophene, beide mit Wirkung zur Behandlung von akuten Atmungsangstanzeichen.
DE69212326D1 (de) Azeotropische zusammensetzungen von 1,1,1,2,3,4,4,5,5,5 decafluoropentan und trans-1,2-dichlorethylen, cis-1,2-dichlorethylen oder 1,1-dichlorethan
DE3884622D1 (de) Schmiermittelzubereitung zur behandlung von rheuma.
DE69528475T2 (de) Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
DE69018457D1 (de) Gegenstände zur behandlung von periodontitis und knochendefekten.
DE69019488T2 (de) Behandlung von Geflügel.
DE3878627D1 (de) Zusammensetzung zur oberflaechenbehandlung von kautschuk.
DE3878417T2 (de) Einrichtung zum teilen von geschlachtetem gefluegel und zum zeitlichen unterbrechen des transportes der karkassen oder teile.
DE69429299T2 (de) Verwendung von Tachykinin-Antagonisten zur Behandlung von Erbrechen
DE69018043T2 (de) Behandlung von Geflügel.
DE3869590D1 (de) Mischung zur behandlung von hypercholesterolemie.
DE3850433D1 (de) Allergiebehandlung und Zusammensetzung dafür.
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
DE69002558D1 (de) Zusammensetzungen und methoden zur verhinderung von inkrustierungen.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE68907569D1 (de) Mittel zur behandlung oder vorbeugung von aids.
DE3586420D1 (de) Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose.
DE69000960D1 (de) Zusammensetzung zur behandlung von pigmentierung.
DE69022027T2 (de) 2-Alkyl-3-benzoylbenzofurane zur Behandlung von Herzarrhythmia.
DE3882023D1 (de) Am aromatischen kern und an der seitenkette fluoratome enthaltende alkoxyaniline und verfahren zur herstellung von am aromatischen kern und an der seitenkette fluoratome enthaltenden alkoxyanilinen.
DE3881377D1 (de) Mittel zur prophylaxe und behandlung von thrombocytopenie.
DE69011565D1 (de) Herstellung von Pre-Kaseinaten und Verwendung.
DE68916814D1 (de) Mittel zur behandlung von pediculosis capitis.
ATE108321T1 (de) Mittel zur behandlung von pediculosis capitis.
DE58902466D1 (de) Acyl-carnitin zur behandlung und zur verhuetung von virusinfektionen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee